Which of the following agents is recommended for treatment of Gastrointestinal Stromal Tumors (GIST) -: (A) Sorafenib, (B) Imatinib, (C) Gefitinib, (D) Erlotinib
Answer is B. Ans. is 'b' i.e., Imatinib Tyrosine kinase inhibitors imatinib and sunitinib are approved for the treatment of Gastrointestinal Stromal Tumors (GIST)